What are the recommended starting doses and titration guidelines for Coversyl Plus (perindopril + indapamide) in adults with normal renal function, moderate or severe renal impairment, elderly patients, and post‑myocardial infarction heart failure?

Coversyl Plus Dosing Guidelines

For adults with normal renal function and hypertension, start Coversyl Plus (perindopril 4 mg/indapamide 1.25 mg) as a single tablet once daily; for elderly patients (>70 years) or those with moderate renal impairment (CrCl 30-60 mL/min), initiate perindopril at 2 mg daily and titrate cautiously; avoid thiazide diuretics including indapamide when GFR <30 mL/min, and Coversyl Plus is contraindicated in severe renal impairment. 1, 2

Starting Doses by Patient Population

Adults with Normal Renal Function (CrCl >60 mL/min)

Hypertension:

• Initial dose: Perindopril 4 mg once daily OR Coversyl Plus (perindopril 4 mg/indapamide 1.25 mg) once daily for stage 2-3 hypertension 1, 3
• Titration: May increase perindopril up to maximum 16 mg/day; usual maintenance 4-8 mg daily 1
• Timing: Take at consistent time daily to improve adherence; no specific advantage to morning vs. evening dosing 4

Stable Coronary Artery Disease:

• Initial dose: Perindopril 4 mg once daily for 2 weeks 1
• Maintenance: Increase to 8 mg once daily as tolerated 1

Elderly Patients (>65-70 years)

For hypertension (age 65-70):

• Start perindopril 4 mg daily in one or two divided doses 1
• Titrate cautiously; limited experience above 8 mg daily 1
• Doses >8 mg require close medical supervision 1

For stable CAD (age >70):

• Week 1: Perindopril 2 mg once daily 1
• Week 2: Increase to 4 mg once daily 1
• Maintenance: 8 mg once daily if tolerated 1

Moderate Renal Impairment (CrCl 30-60 mL/min)

• Initial dose: Perindopril 2 mg once daily 1
• Maximum dose: Do not exceed 8 mg/day due to limited clinical experience 1
• Monitoring: Check blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment, at 3 months, then every 6 months 2, 5

Important caveat: While thiazide-like diuretics (including indapamide) are generally avoided when GFR <30 mL/min 2, 5, they may be used synergistically with loop diuretics in severe heart failure under specialist supervision. However, for routine hypertension management with moderate renal impairment, use perindopril monotherapy initially rather than the fixed combination 6.

Severe Renal Impairment (CrCl <30 mL/min)

• Safety and efficacy NOT established for perindopril 1
• Thiazide diuretics contraindicated except when prescribed synergistically with loop diuretics under specialist care 2, 5
• Coversyl Plus is NOT recommended in this population
• During dialysis, perindopril is removed with normal clearance 1

Post-Myocardial Infarction Heart Failure

ACE inhibitor initiation procedure (applies to perindopril) 2:

1. Review diuretic needs: Reduce or withhold diuretics for 24 hours before starting if possible to minimize hypotension risk 2

2. Starting approach:

   • Consider evening dosing when supine to minimize blood pressure effects (though no specific heart failure data supports this) 2
   • If morning initiation, supervise for several hours with blood pressure monitoring 2

3. Dosing strategy:

   • Start with LOW dose perindopril (2 mg daily in high-risk patients) 1
   • Build up gradually to maintenance doses proven effective in large trials 2
   • For post-MI stable CAD: target 8 mg daily as maintenance 1, 7

4. Avoid during initiation:

   • Potassium-sparing diuretics 2
   • NSAIDs 2

5. Monitoring schedule:

   • Check BP, renal function, and electrolytes 1-2 weeks after each dose increment 2, 5
   • Recheck at 3 months, then every 6 months 2, 5

6. Stopping criteria:

   • Discontinue if renal function deteriorates substantially 2

Critical Considerations When Adding Diuretics

If patient already on diuretics:

• Symptomatic hypotension may occur after first perindopril dose 1
• Preferred approach: Discontinue diuretic 2-3 days before starting perindopril if possible 1
• If diuretic cannot be stopped: Use initial perindopril dose of 2-4 mg daily with careful medical supervision for several hours until BP stabilizes 1
• Resume diuretic if BP not controlled with perindopril alone 1

Combination therapy rationale: The fixed-dose combination (Coversyl Plus) containing very low doses (perindopril 2 mg/indapamide 0.625 mg—half and quarter of usual monotherapy doses respectively) has demonstrated effective BP lowering with good safety profile 8. The standard Coversyl Plus formulation (4 mg/1.25 mg) achieved 71% BP control rates in younger hypertensive patients with low side effect frequency 3.

Common Pitfalls to Avoid

1. Renal function assessment: Always calculate CrCl or eGFR before prescribing—serum creatinine alone is inadequate, especially in elderly patients with reduced muscle mass 9, 10

2. Thiazide use in renal impairment: Do not use thiazide-like diuretics (including indapamide in Coversyl Plus) when GFR <30 mL/min for routine hypertension management 2, 5

3. Excessive diuresis: Avoid volume depletion before ACE inhibitor initiation—this increases first-dose hypotension risk 2, 1

4. Inadequate monitoring: Failure to check renal function and potassium after dose changes can miss dangerous hyperkalemia or acute kidney injury 2, 5

5. Suboptimal dosing in renal impairment: Patients with worse renal function often receive less guideline-directed medical therapy and have worse outcomes—they require MORE attention, not less, with appropriate dose adjustments 11

6. Target achievement timeline: Aim to reach BP target within 3 months to maintain patient confidence and adherence 4